Related Experiment Video

Updated: Jun 12, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Polymyalgia rheumatica: new possibilities for treatment, but not diagnosis]

Willem F Lems1, J W J Hans Bijlsma

  • 1Vrije Universiteit Medisch Centrum, afd. Reumatologie, Amsterdam, The Netherlands. wf.lems@vumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|May 21, 2010
PubMed

Insights

Polymyalgia rheumatica (PMR) is an inflammatory disorder affecting those over 50. Early diagnosis and treatment with prednisone or methotrexate are crucial to prevent complications like vision loss from associated arteritis temporalis.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Clinical Immunology

Context:

  • Polymyalgia rheumatica (PMR) is a common inflammatory condition in older adults.
  • Differentiating PMR from other conditions presents a diagnostic challenge for clinicians.
  • Undiagnosed arteritis temporalis in PMR patients can lead to severe visual impairment.

Purpose:

  • To highlight the diagnostic challenges in polymyalgia rheumatica.
  • To emphasize the importance of considering arteritis temporalis in PMR patients.
  • To outline current therapeutic strategies for PMR.

Summary:

  • PMR is a chronic inflammatory rheumatic disorder primarily affecting individuals aged 50 and above.
  • Accurate differentiation from other diseases is essential, particularly to rule out arteritis temporalis and prevent irreversible visual loss.
  • Most suspected PMR cases respond to prednisone (15 mg/day); methotrexate serves as an alternative for non-responders or those with side effects.

Impact:

  • Improved diagnostic accuracy for polymyalgia rheumatica.
  • Reduced risk of vision loss due to timely diagnosis of associated arteritis temporalis.
  • Optimized patient management through appropriate corticosteroid or methotrexate therapy.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...